Optimization of the efficacy and safety of antidepressant therapy in patients of a geriatric psychiatric unit

Zhurnal Nevrologii i Psihiatrii imeni S.S. Korsakova

Volumn 2015, Issue 6, 2015, Pages 24-32

  Gavrilova, S I ^a   Kalyn, Ya B ^a   Safarova, T P ^a   Yakovleva, O B ^a   Sheshenin, V S ^a   Kornilov, V V ^a   Shipilova, E S ^a  

^a MENTAL HEALTH RESEARCH CENTER   (Russian Federation)

Author keywords

Antidepressant therapy; Carnicetine; Depression; Elderly

Indexed keywords

AGOMELATINE; FLUVOXAMINE; LEVACECARNINE; VENLAFAXINE; ACETAMIDE DERIVATIVE; ACETYLCARNITINE; ANTIDEPRESSANT AGENT; CYCLOHEXANOL DERIVATIVE;

ADULT; AGED; ANXIETY; APATHY; ARTICLE; COGNITIVE DEFECT; COMPARATIVE STUDY; CONTROLLED STUDY; DEPRESSION; DRUG COMBINATION; DRUG EFFICACY; DRUG SAFETY; GERIATRIC PATIENT; HUMAN; MENTAL PATIENT; MONOTHERAPY; RANDOMIZED CONTROLLED TRIAL; UNSPECIFIED SIDE EFFECT; DEPRESSIVE DISORDER; DRUG EFFECTS; FEMALE; MALE; MIDDLE AGED; TREATMENT OUTCOME;

ACETAMIDES; ACETYLCARNITINE; AGED; ANTIDEPRESSIVE AGENTS; APATHY; CYCLOHEXANOLS; DEPRESSIVE DISORDER; DRUG THERAPY, COMBINATION; FEMALE; FLUVOXAMINE; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 84946134369     PISSN: 19977298     EISSN: 23094729     Source Type: Journal    
DOI: 10.17116/jnevro20151156124-32     Document Type: Article

References (17)

1. Blazer D. Depression in late life: review and commentary. Journal of Gerontology. 2003;58(1):3:249-265. doi: 10.1093/gerona/58.3.m249.
2. Baldwin R, Wild R. Management of depression in later life. Advances in Psychiatric Treatment. 2004;10:131-139.
3. Gusev E.I., Kamchatnov P.R. Plastichnost’ nervnoj sistemy. Zhurnal nevrologii i psihiatrii im. S.S. Korsakova. 2004;104(3):73-79.
4. Zhang R, Zhang H, Zhang Z, Wang T, Niu J, Cui D, Xu S. Neuroprotective effects of pre-treatment with L-carnitine and acetyl-L-carnitine of ischemic injury in vivo and in vitro. Int J Mol Sci. 2012;13:2078-2090. doi: 10.3390/ijms13022078.
5. Bersani G, Meco G, Denaro A. L-Acetylcarnitine in dysthymic disorder in eldery patients: a double-blind, multicenter, controlled randomized study vs. fluoxetine. Eur Neuropsychopharmacology. 2013;23:1219-1225. doi: 10.1016/j.euroneuro.2012.11.013.
6. Pattegrew JW, Levine J, McClure RJ. Acetyl-carnitine physical-chemical, metabolic, and therapeutic properties: relevance for its mode of action in Alzheimer’s disease and geriatric depression. Mol Psychiatry. 2000;5:616-632. doi: 10.1038/sj.mp.4000805.
7. Rosca MG, Lemieux H, Hoppel CL. Mitochondria in eldery: is acetylcarnitine a rejuvenator? Adv Drug Deliver Rev. 2009;61(14):1332-1342. doi: 10.1016/j.addr.2009.06.009.
8. Jones LL, McDonald DA, Borum PR. Acetylcarnitines: role in brain. Prog Lipid Res. 2010;49(1):61-75.
9. Pisano C, Pratesi G, Laccabue D. Paclitaxel and cisplatin-induced neurotoxicity: a protective role of acetyl-L-carnitine. Clin Cancer Res. 2003;9(15):5756-5767.
10. Chiechio S, Copani A, DePetris L. Transcriptional regulation of metabotropic glutamate receptor 2/3 expression by the NF- kappa B pathway in primary dorsal root ganglia neurons: a possible mechanism for the analgesic effect of L-acetylcarnitine. Mol Pain. 2006;2:20-28.
11. Madiraju P, Pande SV, Prentki M, Madiraju SR. Mitochondrial acetylcarnitine provides acetyl groups for nuclear histone acetylation. Epigenetics. 2009;4:399-403. doi: 10.4161/epi.4.6.9767.
12. Chiechio S, Copani A, Zammataro M. Transcriptional regulation of type-2 metabotropic glutamate receptors: an epigenetic path to novel treatments. Trends Pharmacol Sci. 2010;31(4):153-160. doi: 10.1016/j.tips.2009.12.003.
13. Zanardi R, Smeraldi E. A double-blind, randomized, controlled clinical trial of acetyl-L-carnitine vs. amisulpride in the treatment of dysthymia. Eur Neuropsychopharmacology. 2006;16:281-287. doi: 10.1016/j.euroneuro.2005.10.005.
14. Nasca C, Xenos D, Barone Y, Caruso A, Scaccianoce S, Matrisciano F. L-acetylcarnitine causes rapid antidepressant effects through the epigenetic induction of mGlu2 receptors. Proc Natl Acad Sci USA. 2013;110(12):4804-4809. doi: 10.1073/pnas.1216100110.
15. Jacobson SA, Pies RW, Katz IR. Clinical manual of geriatric psychopharmacology. American Psychiatric Publishing, Inc (Washington, DC London, England). 2007;17-55.
16. Jacobs BL, van Praag H, Gage FH. Depression and the birth and death of brain cells. Am Sci. 2000;88:340-345. doi: 10.1511/2000.29.775.
17. Bondy B. Pathophysiology of depression. Dialogues in clinical neuroscience. 2002;4:1:7-20.